Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Junshik | - |
dc.contributor.author | Kim, Seok Jin | - |
dc.contributor.author | Chang, Myung Hee | - |
dc.contributor.author | Kim, Jeong-A | - |
dc.contributor.author | Kwak, Jae-Yong | - |
dc.contributor.author | Kim, Jin Seok | - |
dc.contributor.author | Yoon, Dok Hyun | - |
dc.contributor.author | Lee, Won Sik | - |
dc.contributor.author | Do, Young Rok | - |
dc.contributor.author | Kang, Hye Jin | - |
dc.contributor.author | Eom, Hyeon-Seok | - |
dc.contributor.author | Park, Yong | - |
dc.contributor.author | Won, Jong-Ho | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Kim, Hyo Jung | - |
dc.contributor.author | Kwon, Jung Hye | - |
dc.contributor.author | Kong, Jee Hyun | - |
dc.contributor.author | Oh, Sung Yong | - |
dc.contributor.author | Lee, Sunah | - |
dc.contributor.author | Bae, Sung Hwa | - |
dc.contributor.author | Yang, Deok-Hwan | - |
dc.contributor.author | Jun, Hyun Jung | - |
dc.contributor.author | Lee, Ho Sup | - |
dc.contributor.author | Yun, Hwan Jung | - |
dc.contributor.author | Lee, Soon Il | - |
dc.contributor.author | Kim, Min Kyoung | - |
dc.contributor.author | Yi, Jun Ho | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Kim, Won Seog | - |
dc.contributor.author | Suh, Cheolwon | - |
dc.date.available | 2020-02-27T16:42:42Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-11-03 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5473 | - |
dc.description.abstract | The National Comprehensive Cancer Network (NCCN)-International Prognostic Index (IPI) and GELTAMO (Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea)-IPI were developed to enable better risk prediction of patients with diffuse large B-cell lymphoma (DLBCL). The present study compared the effectiveness of risk prediction between IPI, NCCN-IPI, and GELTAMO-IPI in patients with DLBCL particularly in terms of determining high-risk patients. Among 439 patients who were enrolled to a prospective DLBCL cohort treated with R-CHOP immunochemotherapy, risk groups were classified according to the three IPIs and the prognostic significance of individual IPI factors and IPI models were analyzed and compared. All three IPI effectively separated the analyzed patients into four risk groups according to overall survival (OS). Estimated 5-year OS of patients classified as high-risk according to the IPI was 45.7%, suggesting that the IPI is limited in the selection of patients who are expected to have a poor outcome. In contrast, the 5-year OS of patients stratified as high-risk according to NCCN- and GELTAMO-IPI was 31.4% and 21.9%, respectively. The results indicate that NCCN- and GELTAMO-IPI are better than the IPI in predicting patients with poor prognosis, suggesting the superiority of enhanced, next-generation IPIs for DLBCL. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.subject | EXTRANODAL INVOLVEMENT | - |
dc.subject | RITUXIMAB ERA | - |
dc.subject | R-IPI | - |
dc.subject | SURVIVAL | - |
dc.subject | BETA(2)-MICROGLOBULIN | - |
dc.subject | BETA-2-MICROGLOBULIN | - |
dc.subject | VALIDATION | - |
dc.subject | TRANSPLANTATION | - |
dc.subject | EXPRESSION | - |
dc.subject | SIGNATURES | - |
dc.title | Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000414606800029 | - |
dc.identifier.doi | 10.18632/oncotarget.20988 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.8, no.54, pp.92171 - 92182 | - |
dc.identifier.scopusid | 2-s2.0-85032686702 | - |
dc.citation.endPage | 92182 | - |
dc.citation.startPage | 92171 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 8 | - |
dc.citation.number | 54 | - |
dc.contributor.affiliatedAuthor | Lee, Jae Hoon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | non-hodgkin lymphoma | - |
dc.subject.keywordAuthor | diffuse large B-cell lymphoma | - |
dc.subject.keywordAuthor | international prognostic index | - |
dc.subject.keywordAuthor | prognosis | - |
dc.subject.keywordAuthor | overall survival | - |
dc.subject.keywordPlus | EXTRANODAL INVOLVEMENT | - |
dc.subject.keywordPlus | RITUXIMAB ERA | - |
dc.subject.keywordPlus | R-IPI | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | BETA(2)-MICROGLOBULIN | - |
dc.subject.keywordPlus | BETA-2-MICROGLOBULIN | - |
dc.subject.keywordPlus | VALIDATION | - |
dc.subject.keywordPlus | TRANSPLANTATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | SIGNATURES | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.